Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers

by Adam J. Nelson, Maddalena Ardissino, Peter J. Psaltis
Published 2019-10-01

Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes

by Hussam M Tayeb, Adam J Nelson, Scott R Willoughby, et al
Published 2010-12-01

Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine

by Angus A. W. Baumann, Aashka Mishra, Matthew I. Worthley, Adam J. Nelson, Peter J. Psaltis
Published 2020-06-01

Reply: Lead-preserving Strategies for Pacemaker Pocket Infection: Who, When and How?

by Adam J. Nelson, BMedSc(hons) MBBS, Rishi Puri, MBBS FRACP, Peter J. Psaltis, MBBS FRACP, Prashanthan Sanders, MBBS PhD FRACP, Glenn D. Young
Published 2012-11-01

Erratum to “C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV” [American Journal of Preventive Cardiology 3C (2020) 100091]

by Adam J. Nelson, Rishi Puri, Danielle M. Brennan, Todd J. Anderson, Leslie Cho, Christie M. Ballantyne, John JP. Kastelein, Wolfgang Koenig, Helina Kassahun, Ransi M. Somaratne, Scott M. Wasserman, Steven E. Nissen, Stephen J. Nicholls
Published 2021-06-01

C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV

by Adam J. Nelson, Rishi Puri, Danielle M. Brennan, Todd J. Anderson, Leslie Cho, Christie M. Ballantyne, John JP. Kastelein, Wolfgang Koenig, Helina Kassahun, Ransi M. Somaratne, Scott M. Wasserman, Steven E. Nissen, Stephen J. Nicholls
Published 2020-09-01